What's new

EMEA-002656-PIP01-19-M01

EMEA-002656-PIP01-19-M01

Apr 2, 2025 - 15:37
 0
EMEA-002656-PIP01-19-M01
EMEA-002656-PIP01-19-M01
Read More

Tags:

Previous Article

EMEA-002565-PIP02-19-M01

Next Article

Human medicines European public assessment report (EPAR): Synjardy, empagliflozi...

Related Posts

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Questions and answers for biological medicinal products

Questions and answers for biological medicinal products

Feb 25, 2025  0